Increasing Regulatory Burden on UK Pharma Fuels Need for E-Discovery Solution
AccessData just released a new white paper that discusses the growing litigation risks and regulatory pressures on UK pharmaceutical companies and the need for technology solutions to e-discovery.
The management of electronic data is a complex and time-consuming challenge for corporate legal executives in any industry. These challenges are especially acute for UK companies in the pharmaceutical industry where corporate executive teams are faced with managing electronic data that resides on email servers and other data repositories. Pharmaceutical companies face an even greater e-discovery challenge when it comes to harvesting data from restricted information sources such as clinical trial records, adverse reaction findings and highly confidential sales analysis reports.
The challenges are great but the technology is there. This white paper details key strategies to help pharmaceutical executives better manage their e-discovery responsibilities.
Download the White Paper